West Announces First-Quarter 2021 Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. SAP
7. LRCX
8. MRK
9. LVS
10. CSX

Go back to West Announces First-Quarter 2021 Results

West Pharma (WST) Tops Q1 EPS by 62c, Revenues Beat; Offers FY21 EPS/Revenues Guidance Above Consensus

April 29, 2021 6:14 AM EDT

West Pharma (NYSE: WST) reported Q1 EPS of $2.05, $0.62 better than the analyst estimate of $1.43. Revenue for the quarter came in at $670.7 million versus the consensus estimate of $611.39 million.

First-Quarter 2021 Summary (comparisons to prior-year period)

Net sales of $670.7 million grew 36.5%; organic sales growth was 31.1%.Reported-diluted EPS of $1.99 increased 101%.Adjusted-diluted EPS of $2.05 increased 103%.The Company is raising full-year 2021 net sales guidance to a new range of $2.630 billion to $2.655 billion, compared to a prior range of $2.500 billion to $2.525 billion. The Company is raising full-year 2021 adjusted-diluted EPS guidance to a new... More